OptimizeRx Corp (OPRX) AI Dilution Summary

OptimizeRx reported cash of $24,096,000 at the 2026-06-30 balance-sheet date. After that date, on 2026-07-09, it made a $3,000,000 cash prepayment of principal on the New Term Loan under its May 7, 2026 Credit Agreement. The main source of potential dilution is the active S-3 shelf registration 333-286224.